Yahoo Finance

Camallergy and OnDosis Announce a Groundbreaking Partnership to Revolutionize Food Allergy Treatment

CAMBRIDGE, England & GOTHENBURG, Sweden, November 29, 2023--(BUSINESS WIRE)--Camallergy, a pioneer in developing oral immunotherapy treatments for food allergies, and OnDosis, a leader in intelligent ...
PharmiWeb

Camallergy’s UK Based Manufacturing Facility Receives cGMP Licences for Peanut Allergy Treatment

CAMBRIDGE, England--(BUSINESS WIRE)--Cambridge Allergy Ltd (“Camallergy” or “the Company”), a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for ...
Business Wire

Camallergy Provides Corporate Update and Prepares to Advance Lead Candidate CA002 Into Phase 3 Efficacy Trial for Peanut Allergy

CAMBRIDGE, England--(BUSINESS WIRE)--Cambridge Allergy Ltd (“Camallergy” or “the Company”), a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for ...
Finanznachrichten

Camallergy Chief Medical Officer to Present New Clinical Data from Cambridge Peanut Allergy Clinic at AAAAI Annual Meeting

Presentations will highlight patient outcomes of tolerability, safety and real-world efficacy of Camallergy's peanut oral immunotherapy for the treatment of peanut allergy Cambridge Allergy Ltd ...
The Globe and Mail

Camallergy Awarded £1.1 M Funding Under Innovate UK Biomedical Catalyst Award for Novel Peanut Allergy Treatment

Cambridge Allergy Ltd (“Camallergy” or “the Company”), a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced it ...
Finanznachrichten

Camallergy and OnDosis Announce a Groundbreaking Partnership to Revolutionize Food Allergy Treatment

Camallergy, a pioneer in developing oral immunotherapy treatments for food allergies, and OnDosis, a leader in intelligent dosing of oral solid medicines, are excited to announce a strategic ...